The FRIEND Project is working in the development of a regional synthesis of the mail aspects included in the national communications to the United Nation Convention on Climatic Change.
The novel antisense oligonucleotide works by inhibiting the synthesis of apo-B and is under development in the United States and Europe for the treatment of familial hypercholesterolemia.